Boston Scientific price target raised to $20 — 4 things to know

Boston Scientific’s price target was raised by Barclays from $19 to $20, according to a Sleek Money report.

Advertisement

Here are four things to know about the stock:

•    Boston Scientific stock has an average rating of buy.
•    The company has a one-year low of $11.10 and a one-year high of $18.17.
•    The stock’s 50-day moving average is $16 and its 200-day moving average is $13.
•    Boston Scientific’s market cap is $23.95 billion.

More articles on gastroenterology:
6 gastroenterologists making headlines – March 20, 2015
Morgan Stanley sets Boston Scientific price target at $20
AGA Diversity Committee expands sessions for DDW 2015

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.